Sustol (granisetron) is a medication used to prevent nausea and vomiting due to cancer medications (chemotherapy) in adults. It can last for up to 7 days.
Prevention of nausea and vomiting caused by chemotherapy
Sustol (granisetron) is an antiemetic medication. It works by blocking the actions of serotonin (a chemical in your body) in the part of your brain that causes nausea and vomiting. This helps you feel less nauseous and less of an urge to vomit.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Works well for preventing nausea
Lasts for up to 7 days
Good option for people who have a hard time taking pills
Must be given by a healthcare provider as an injection under the skin
Not clear how safe the medication is in pregnant or breastfeeding females
Can't be used in children
Sustol (granisetron) is given by a healthcare provider right before your chemotherapy. It's given as an injection under your skin either in the back of your upper arm or stomach. The injection can last for up to 30 seconds.
After your Sustol (granisetron) injection, be sure to check the injection site every day for injection-related reactions. These can include bleeding, bruising, swelling, and signs of an infection. Injection-site reactions can appear up to 2 weeks or more after your injection. Contact your provider if any reactions become severe or last longer than 1 day.
To lower your risk for injection site reactions, it's important that your provider rotate Sustol (granisetron) sites with each injection. Write down or make a note of where your provider injected Sustol (granisetron) so that you can remind them to inject at a different location next time.
Let your provider know if there's a change in your bowel movements. Sustol (granisetron) can cause constipation, even days after your injection. If left untreated, sometimes constipation can lead to serious problems, such as blocked intestines. Your provider might be able to recommend ways to lower your risk for constipation or prescribe medications to treat constipation.
Sustol (granisetron) can interact with medications that raise the level of serotonin in your body, such as certain antidepressants. This can lead to a dangerous side effect called serotonin syndrome. Make sure to tell your provider about all the medications you take before starting Sustol (granisetron). Let your provider know if you've symptoms of serotonin syndrome, such as sweating, shaking, and trouble sleeping.
Sustol (granisetron) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
When you receive Sustol (granisetron), you might experience complications at the injection site. These can include infections, bleeding, bruising, and pain. Since the medication is long-lasting, these reactions can appear several days to weeks after your injection, and last for weeks at a time. Contact your provider if your reactions are severe, if you think you have an infection, or you have bleeding that lasts longer than a day.
Risk factors: Taking other medications that raise serotonin levels in your brain
Some people taking Sustol (granisetron) have developed a rare, but potentially life-threatening condition called serotonin syndrome. This condition happens where there's too much serotonin in the brain. Your risk for serotonin syndrome goes up if you use Sustol (granisetron) with other medications that can raise your serotonin levels, such as certain antidepressants, mental health medications, pain medications, and migraine medications.
Let your provider know about all the medications you take before starting Sustol (granisetron). Also, don't start any new medications without talking to your provider first. Symptoms of serotonin syndrome include fast heart rate, sweating, muscle stiffness or spasms, fever, and confusion. Get medical help right away if you have any of these symptoms.
Some people have experienced a severe allergic reaction to Sustol (granisetron). These reactions can be life-threatening and include facial swelling, hives, and anaphylaxis (e.g., closing of the throat). Because Sustol (granisetron) lasts for about a week in your body, you might experience an allergic reaction up to 7 days or longer after your injection. If you notice dizziness, fast heartbeat, a choking sensation, difficulty breathing, swelling around your eyes, swelling of the lips or tongue, or any signs of a severe skin reaction after taking Sustol (granisetron), get medical attention right away.
Risk factors: Stomach surgery | Taking opioid medications
Sustol (granisetron) can cause stomach problems, such as constipation and intestinal blockage. Contact your provider if you have constipation, trouble passing gas, and pain or swelling in your stomach area. These could be signs of serious stomach problems that need treatment.
The typical dose is 10 mg injected under the skin in the back of your upper arm or stomach by a healthcare provider at least 30 minutes before chemotherapy.
Sustol (granisetron) is given on day 1 of chemotherapy and then up to once every 7 days thereafter.
Allergy to serotonin antagonist
Prevention of nausea and vomiting from chemotherapy in adults and children 1 month of age and older
Prevention of nausea and vomiting (for up to 24 hours) after surgery in adults
Prevention of nausea and vomiting due to cancer medications (chemotherapy) or radiation therapy
Prevention of nausea and vomiting after surgery
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Heron Therapeutics, Inc. (2023). Sustol- granisetron injection [package insert]. DailyMed.
Ngo, A. L., et al. (2019). Extended release granisetron: Review of pharmacologic considerations and clinical role in the perioperative setting. Saudi Journal of Anaesthesia.
Ruggiero, A., et al. (2018). Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment. Journal of International Medical Research.
Schnadig, I. D., et al. (2017). APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: A post hoc subgroup analysis of the Phase III randomized MAGIC trial. Cancer Management and Research.
Theriot, J., et al. (2022). Antiemetic serotonin 5-HT3 receptor blockers. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.